Clinical Trial Update: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nebivolol for cardioprotective effects during anthracycline chemotherapy in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cardiotoxicity
• Left Ventricular Dysfunction
• Lymphoma Large B-cell Diffuse

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Giulio Stefanini | Conditions: Breast Cancer, Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: UNKNOWN